Medical history, goals, tolerance, current medications, and monitoring needs should guide the decision
The biggest concern for many people is losing the progress theyve made, Dr
WEGOVY injection significantly reduced the risk for first occurrence of MACE
FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014
Real-World Timeline Heres what the journey typically looks like: First month (0.25 mg): Youll notice reduced appetite before seeing major scale changes
Compared with placebo, semaglutide 2.0 mg (risk ratio = 7.73 [95% CI 5.62, 10.63]) and tirzepatide 15 mg (risk ratio = 7.01 [95% CI 5.73, 8.57]) were the most efficacious in achieving an HbA 1c target of 48 mmol/mol (6.5%) (ESM Table 9)